semaglutide retatrutide tirzepatide vs vs Compared GLP-1 Medications for Weight Loss:

GLP-1 Case Study Name: Richard J., a 58-year-old male Medical History: Type 2 Diabetes Mellitus (diagnosed 7 years ago) Obesity (BMI 35 kg/m) Hypertension (well-controlled on an ACE inhibitor) Mild diabetic retinopathy Current Medications: Metformin 1000 mg twice daily, glimepiride 2 mg once daily, and lisinopril 20 mg once daily Clinical Presentation Richard presents a routine follow-up

Withdrawal symptoms can also occur when individuals stop taking GLP-1 medications: Reduced side effects: While semaglutide or tirzepatide can lead to side effects like acid reflux, nausea, constipation and abdominal pain, stopping the medication can reduce these side effects

insulin glargine for all)

Native GLP-1 was recognized as a potential drug target by the late 1980s

Why should another drug change how we face obesity

If air bubbles are present, tap the syringe gently and push the air out before redrawing the dose if needed